Matches in Nanopublications for { ?s ?p "[Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for anticancer therapy; however, non-small-cell lung carcinoma (NSCLC) cells are relatively TRAIL resistant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for anticancer therapy; however, non-small-cell lung carcinoma (NSCLC) cells are relatively TRAIL resistant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1249258.RAeZhS_wxCsBTAsxd8RsQJgXJpEdjQk4dicYNksocNSUs130_assertion description "[Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for anticancer therapy; however, non-small-cell lung carcinoma (NSCLC) cells are relatively TRAIL resistant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249258.RAeZhS_wxCsBTAsxd8RsQJgXJpEdjQk4dicYNksocNSUs130_provenance.